Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-981]
 AGENCY: Drug Enforcement Administration, Justice.
 ACTION: Notice of application.
 SUMMARY: Sigma Aldrich Co. LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
 DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 13, 2022. Such persons may also file a written request for a hearing on the application on or before April 13, 2022.
 ADDRESSES: DEA requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to 
                        *https://www.regulations.gov*
                         and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on 
                        *https://www.regulations.gov.*
                         If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152.


SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a)
                    *,*
                     this is notice that on January 21, 2022, Sigma Aldrich Co. LLC, 3500 Dekalb Street, Saint Louis, Missouri 63118-4103, applied to be registered as an importer of the following basic class(es) of controlled substance(s): Controlled substance
Drug code
ScheduleCathinone
1235
IMethcathinone
1237
IMephedrone (4-Methyl-N-methylcathinone)
1248
IGamma Hydroxybutyric Acid
2010
ITetrahydrocannabinols
7370
I4-Bromo-2,5-dimethoxyamphetamine
7391
I4-Bromo-2,5-dimethoxyphenethylamine
7392
I2,5-Dimethoxyamphetamine
7396
I3,4-Methylenedioxyamphetamine
7400
I3,4-Methylenedioxy-N-ethylamphetamine
7404
I3,4-Methylenedioxymethamphetamine
7405
I4-Methoxyamphetamine
7411
IDimethyltryptamine
7435
IN-Benzylpiperazine
7493
IHeroin
9200
INormorphine
9313
IAmobarbital
2125
IISecobarbital
2315
IINabilone
7379
IIPhencyclidine
7471
IIEcgonine
9180
IIEthylmorphine
9190
IILevorphanol
9220
IIMeperidine
9230
IIThebaine
9333
IIOpium, powdered
9639
IILevo-alphacetylmethadol
9648
II
 
 
 The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. In reference to drug code 7370 (Tetrahydrocannabinols) the company plans to import synthetic Tetrahydrocannabinols. No other activity for this drug code is authorized for this registration. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale. Matthew J. Strait, Deputy Assistant Administrator.


[FR Doc. 2022-05318 Filed 3-11-22; 8:45 am] BILLING CODE P